Moderna
MRNA
$0.63 (-1.18%)
1D
1W
3M
1Y
5Y
ALL
Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. The Company develops technologies that enable the development of mRNA medicines for diverse applications. It has created modalities, including prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, and systemic intracellular therapeutics.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Accesswire • 9 hours ago • MRNA
Moderna Named a Top Employer by Science for Tenth Consecutive YearSeeking Alpha • 2 days ago • MRNA
We Think Moderna Still Has A FutureZacks Investment Research • 3 days ago • MRNA
Why Moderna (MRNA) Dipped More Than Broader Market TodaySeeking Alpha • 4 days ago • MRNA
Top 7 Tax-Loss Stocks To Sell By October 31, 2024Investors Business Daily • 4 days ago • MRNA
Don't Get Caught Holding 7 Stocks About To Shrink 30% Or MoreCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.